A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers

Trial Profile

A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2016

At a glance

  • Drugs Monascus (Primary) ; Lovastatin
  • Indications Hyperlipidaemia
  • Focus Pharmacokinetics
  • Sponsors Luye Pharma Group
  • Most Recent Events

    • 31 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 17 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top